Wiltrom Co (6767.TWO) Stock Price

Wiltrom Co., Ltd. generates revenue through the research, production, and distribution of high-end medical devices, including spinal fixators, artificial bones, and interbody fusion cages. The company focuses on Class II and Class III implantable devices, targeting spinal fusion surgery, spinal compression fracture surgery, and bone cement product segments. Its primary markets are Taiwan, Asia, and America, where it sells directly to hospitals and medical institutions. The firm's product portfolio is designed for specialized surgical procedures, with spinal fusion surgery products forming a core segment of its business. The company's revenue streams are derived from the sale of spinal fixators, artificial bones, and interbody fusion cages, which are categorized under spinal fusion surgery, spinal compression fracture surgery, and bone cement product segments. These products are distributed across Taiwan, Asia, and America, with a strong emphasis on the spinal fusion surgery market. Wiltrom's focus on high-end, implantable Class II and Class III medical devices ensures a premium pricing strategy, aligning with the specialized needs of surgical procedures. Wiltrom Co., Ltd. serves healthcare providers in Taiwan, Asia, and America, delivering Class II and Class III medical devices for spinal fusion, spinal compression fracture, and bone cement applications. The company's products are tailored to specific surgical segments, with spinal fusion surgery products representing a significant portion of its sales. Revenue is generated through direct sales to hospitals and medical institutions within its key geographic markets.